← Home
Cautionary Tales · March 15, 2022 · 40m
The Fake Blood Test and the Billionaire Con
Cautionary Tales
Theranos and Elizabeth Holmes — how a Stanford dropout raised $700 million for blood-testing technology that didn't work, deceived investors, endangered patients, and became Silicon Valley's most famous fraud.
Highlights
•
Storytelling skills can substitute for substance in environments that reward confidence over competence
Holmes succeeded not because her technology worked but because she told a compelling story: 'One drop of blood can run hundreds of tests.' Investors bought the narrative because they wanted to believe in revolutionary simplicity.•
Regulatory gaps allow fraud to scale — Theranos exploited the gap between medical and tech regulation
Theranos operated in a regulatory no-man's-land: too tech for medical regulators, too medical for tech regulators. The gap between regulatory jurisdictions enabled a fraud that endangered patients.